More evidence that antipsychotics are dangerous in dementia
The Carlat Psychiatry Report, Volume 5, Number 7, July 2007
https://www.thecarlatreport.com/newsletter-issue/tcprv5n7/
Issue Links: Learning Objectives | Editorial Information
Topics: Antipsychotics
Jesse H. Wright, MD
In 2005, the FDA issued a health advisory saying that antipsychotics appear to increase the risk of death in elderly patients with dementia. That advisory was based on data from placebo-controlled trials of antipsychotics conducted by industry. Now, a new study based on a completely different, and much larger, dataset, appears to confirm these dangers.
You can't view details of this content, please login or buy subscription here
Jesse H. Wright, MD
Professor and Chief of Adult Psychiatry, University of Louisville School of Medicine, Co-author, Learning Cognitive Behavior Therapy: An Illustrated Guide
Dr. Wright has disclosed that he receives royalities from books he has written about cognitive behavioral therapy.